FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Birlasoft Limited Buyback and Zydus Lifesciences Buyback.
Birlasoft Limited Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Zydus Lifesciences Buyback is a Tender Offer proposed to list at BSE, NSE.
Birlasoft Limited | Zydus Lifesciences Limited | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Logo | ||||||||||||||
Type of Buyback | Tender Offer | Tender Offer | ||||||||||||
Listing At | BSE, NSE | BSE, NSE | ||||||||||||
Face Value | ₹2 per share | ₹1 per share | ||||||||||||
Buyback Price | ₹500 per share | ₹650 per share | ||||||||||||
Issue Size | 78,00,000 shares | 1,15,38,461 shares | ||||||||||||
Issue Size (Amount) | ₹390.00 Crores | ₹750.00 Crores | ||||||||||||
Buyback Ratio |
|
|
||||||||||||
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd | ||||||||||||
Lead Managers | Kotak Mahindra Capital Company Limited | ICICI Securities Limited | ||||||||||||
Necessity of the buyback | The buyback is being undertaken for the following reasons: 1. The Buyback will help the Company to distribute surplus cash to its members holding Equity Shares thereby enhancing the overall return for them. 2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value. |
The buyback is being undertaken for the following reason: 1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity. |
Birlasoft Limited Buyback and Zydus Lifesciences Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Birlasoft Limited Buyback Buyback record date is Jul 15, 2022. Zydus Lifesciences Buyback Buyback record date is Jun 02, 2022.
Birlasoft Limited | Zydus Lifesciences Limited | |
---|---|---|
Record Date | Jul 15, 2022 | Jun 02, 2022 |
Offer Open Date | Aug 11, 2022 | Jun 23, 2022 |
Offer Closure Date | Aug 26, 2022 | Jul 06, 2022 |
Last date for receipt of tender forms | Aug 26, 2022 | Jul 06, 2022 |
Finalisation of buyback | Sep 06, 2022 | Jul 14, 2022 |
Last Date for settlment of bids | Sep 07, 2022 | Jul 15, 2022 |
Last Date for extinguishment of shares | Sep 14, 2022 | Jul 22, 2022 |
Comparison of Birlasoft Limited Buyback and Zydus Lifesciences Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.
Birlasoft Limited | Zydus Lifesciences Limited | |||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||
Stock price at BSE | Stock price at BSE (in preceding 3 months)
|
Stock price at BSE (in preceding 3 months)
|
||||||||||||||||||||||||||||||||||||||||
Stock price at NSE | Stock price at NSE (in preceding 3 months)
|
Stock price at NSE (in preceding 3 months)
|
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|